AAP
42
18
LH
48
5
IRM
50
3
ED
52
4
AKAM
53
2
PFG
50
5
MRK
33
8
STI
31
17
HSY
38
3
VRSK
80
3
F
60
2
TRV
58
2
IBM
61
3
KSS
46
12
MHK
55
6
DOW
46
2
PHM
70
11
RL
78
6
SO
59
6
TJX
69
5
AAP
42
18
LH
48
5
IRM
50
3
ED
52
4
AKAM
53
2
PFG
50
5
MRK
33
8
STI
31
17
HSY
38
3
VRSK
80
3
F
60
2
TRV
58
2
IBM
61
3
KSS
46
12
MHK
55
6
DOW
46
2
PHM
70
11
RL
78
6
SO
59
6
TJX
69
5
Financhill
Back

Novo Nordisk AS Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42

NVO
Novo Nordisk AS

Last Price:
106.12
Seasonality Move:
9.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

Novo Nordisk AS Price Quote

$106.12
+1.56 (+1.49%)
(Updated: November 26, 2024 at 5:55 PM ET)

Novo Nordisk AS Key Stats

Sell
42
Novo Nordisk AS (NVO) is a Sell
Day range:
$104.00 - $105.92
52-week range:
$94.73 - $148.15
Dividend yield:
1.38%
P/E ratio:
38.68
P/S ratio:
11.87
P/B ratio:
25.73%
Volume:
4.2M
Avg. volume:
5.8M
1-year change:
-0.84%
Market cap:
$464.5B
Revenue:
$33.7B
EPS:
$3.09

How Much Does Novo Nordisk AS Make?

Is Novo Nordisk AS Growing As A Company?

  • What Is Novo Nordisk AS's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is Novo Nordisk AS's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.24%

Novo Nordisk AS Stock Price Performance

  • Did Novo Nordisk AS Stock Go Up Last Month?
    Novo Nordisk AS share price went down by -7.78% last month
  • Did NVO's Share Price Rise Over The Last Year?
    NVO share price fell by -0.84% over the past 1 year

What Is Novo Nordisk AS 52-Week High & Low?

Novo Nordisk AS Price To Free Cash Flow

Is It Risky To Buy Novo Nordisk AS?

  • How Much Debt Does Novo Nordisk AS Have?
    Total long term debt quarterly is $8.5B
  • How Much Cash Does Novo Nordisk AS Have?
    Cash and short term investments quarterly total is $11.2B
  • What Is Novo Nordisk AS’s Book Value Per Share?
    Book value per share is 4.06

Is Novo Nordisk AS Cash Flow Positive?

  • What Is NVO Cash Flow From Operations?
    Cash flow from operations (TTM) is $17.3B
  • What Is Novo Nordisk AS’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$5.6B
  • What Is Novo Nordisk AS’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$7.7B

Novo Nordisk AS Return On Invested Capital

  • Is Management Doing A Good Job?
    NVO return on invested capital is 65.63%
  • What Is Novo Nordisk AS Return On Assets?
    ROA measures how assets are converting to revenues and is 28.14%
  • What Is NVO Return On Equity?
    ROE is a measure of profitability and is 88.95%

Novo Nordisk AS Earnings Date & Stock Price

Novo Nordisk AS Competitors

  • Who Are Novo Nordisk AS's Competitors?
    Below is a list of companies who compete with Novo Nordisk AS or are related in some way:
    • Amgen Inc (AMGN)
    • Ascendis Pharma AS (ASND)
    • AstraZeneca PLC (AZN)
    • Evaxion Biotech AS (EVAX)
    • Viking Therapeutics Inc (VKTX)

Novo Nordisk AS Dividend Yield

Novo Nordisk AS Analyst Estimates

YoY Growth Past Surprise
EPS: 23.52% 0%
Revenue: 22.53% -0.31%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 2
Sell Recommendations: 1
Price Target: 133.01
Upside from Last Price: 27.21%

Major Shareholders

  • How many NVO shares are owned by institutional investors?
    448.1M NVO shares are owned by institutional investors
  • How many NVO shares are owned by insiders?
    0 NVO shares are owned by insiders